- 1Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Puncak Alam Campus, Shah Alam, Malaysia
- 2Department of Pharmacy Practice, Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan
- 3School of Pharmacy, Monash University, Subang Jaya, Malaysia
- 4Vector-Borne Diseases Research Group (VERDI), Pharmaceutical and Life Sciences CoRe, Universiti Teknologi MARA (UiTM), Shah Alam, Malaysia
- 5Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Cawangan Pulau Pinang, Kampus Bertam, Shah Alam, Malaysia
- 6Monash University Malaysia, Subang Jaya, Malaysia
Background: Male infertility is an emerging health issue in the world today. Surgical interventions for the treatment of male infertility are available but are quite expensive. Herbal interventions pose a popular alternative for the treatment of infertility. However, much has to be learned regarding their safety and efficacy.
Objective: The aim of the study was to investigate the efficacy of herbal interventions in male infertility and also assess the possibility of these interventions as complementary and alternative medicine (CAM) in the future.
Method: From inception until 16 December 2021, all articles emphasizing the efficacy of herbal interventions in the treatment of male infertility are included in this review. Seven databases are searched. The literature obtained is screened and extracted. Semen parameters, hormonal concentration, and conception are the outcomes of interest.
Results: A total of 19 articles were included in this review. Herbal interventions might improve semen parameters in males with infertility. Among all the interventions, Hochu-ekki-to and W. somnifera have shown the most promising results and should be studied further in a larger sample size.
Conclusion: This systematic review has demonstrated the efficacy of herbal interventions, especially Hochu-ekki-to and W. somnifera, in treating male infertility.
Introduction
Infertility is defined as failure to achieve clinical conception despite unprotected intercourse for 1 year (Rowe et al., 2000). According to the World Health Organization (WHO), 12 months is the lowest reference limit for time to pregnancy (TTP) (Makar and Toth, 2002). According to surveys, a total of 48.3 million (15%) couples worldwide are affected by any kind of infertility, and higher infertility rates are observed in Central Europe and Africa (Kuoti Al-Rekabi et al., 2019). In Pakistan, the prevalence of infertility is approximately 22% (Sami and Saeed Ali, 2012). Males contribute to 20–70% of all infertile cases in Pakistan (Agarwal et al., 2015), while in the United States, (US) 9% of males aged 15–44 years are affected by infertility (Esteves et al., 2012). Lack of knowledge about the factors affecting fertility in males ultimately causes some males to engage in various unethical activities that affect their biological life and their ability to produce sufficient healthy sperms for successful pregnancy in a woman (Chachamovich et al., 2010).
The etiology of male infertility is multifactorial. A total of 60% of all male infertility cases is caused by sperm dysfunction (Wright et al., 2014). Poor sperm quality and reduced sperm count are the major factors in male infertility. Sperm quality can be assessed by three primary endpoints, that is, sperm concentration, morphology, and motility (Buhling et al., 2019). Male infertility may be caused by urogenital infections, chromosomal abnormalities, urogenital carcinoma (Wang et al., 2020a), alteration in genital hormones (Dutta et al., 2019), and unhealthy lifestyle (Daumler et al., 2016). In 30–80% of cases, sperm damage is postulated to have resulted from oxidative stress caused by reactive oxidative species (ROS). This oxidative stress damages the DNA of sperms which ultimately decreases sperm motility, damages the membrane of the acrosome, and decreases the ability of the sperm to fertilize the oocyte (Barati et al., 2020).
Various treatment modalities including pharmacological and herbal interventions, laboratory methods, and surgical interventions are available to treat male infertility (Sinclair, 2000). Among the interventions, many couples opt for complementary and alternative medicines (CAM) due to their availability, affordability, and accessibility (Smith et al., 2010). The herbal products are believed to have several nutritional values and biological effects in treating male infertility (Abdi et al., 2017). Several plants contain flavonoids and phenolic compounds which are potent antioxidants and are highly effective in improving the quality of sperms (Rekka et al., 1996). Recently, the European Association of Urology has acknowledged the use of complementary herbal medicines to treat male infertility (Nejatbakhsh et al., 2016). However, the World Health Organization (WHO) still has some concerns regarding the insufficient scientific knowledge on the compounds of the medicinal plants. Thus, it is necessary to identify the natural active biological compounds in plants that have specified positive effects on male infertility (Marbeen et al., 2005; Roozbeh et al., 2021). Following identification, the said compounds can then be extracted, purified, and formulated to be used in the future.
Male infertility is a prevalent issue in Pakistan, and the use of herbal interventions is also prevalent in the country for various diseases. Many people in Pakistan tend to lean toward herbal medicines rather than allopathic treatments. Moreover, no study has been conducted to evaluate the efficacy of herbal interventions in the treatment of male infertility. This systematic review is aimed to summarize the results of all the accessible studies that fulfill the inclusion criteria to determine the efficacy parameters of herbal interventions in male infertility.
Methodology
Literature searching techniques
Seven electronic databases (PubMed, Scopus, Cochrane Library, Embase, EBSCOhost, Ovid, and Google Scholar) were searched for data sources and strategies from inception until 31 December 2021. Medical Subject Headings [MeSH] and text terms were included for search terms in this review. The strategic search terms are “herbal medicine” or “herbal” or “herbalism” or “herbals” or “homeopathy” AND “infertility” or “subfertility” or “subfertile” or “azoospermia” or “oligospermia” or “oligozoospermia” or “oligoasthenoteratozoospermia” or “genital disease” or “genitalia” or “genital” or “low sperm count” or “semen.” Details of search strategies used for each database are provided in the supplementary files.
Inclusion and exclusion criteria
The PICOT framework was adopted to define the inclusion criteria (Table 1). The inclusion criteria are as follows.
Studies that were included comprise (Rowe et al., 2000) randomized control trials or cluster-randomized controlled trials; (Makar and Toth, 2002) different herbal interventions (including homeopathic) evaluating the efficacy of men infertility issues (Kuoti Al-Rekabi et al., 2019) directed at male patients (≥18 years) with infertility only; (Sami and Saeed Ali, 2012) experimental single-case studies; (Agarwal et al., 2015) an original study published in a peer-reviewed journal; and (Esteves et al., 2012) article in the English language. Cross-sectional studies, in vitro studies, study protocols, expert opinions, case reports/series, editorials, abstracts from conferences, review articles, and studies involving animals were excluded.
Study selection
Two reviewers MRY and TAS screened titles and abstracts extracted from various databases using the well-defined selection criteria. Appropriate articles were then screened individually by the reviewers MNS and AB to access their inclusion eligibility. Resolution of disagreement was primarily through discussion.
Data extraction and qualitative synthesis
Data extraction was performed individually for all the selected articles by HSA, BF, and MRI. The extracted data were then reviewed by MNS and AB for proper extraction. Details about publication year, authors, design of the study, country, sample size, age of the patients, interventions, and outcomes of the study were extracted from each included study. The outcomes were summarized in the form of the changes in parameters from baseline up to the end of intervention for the patients of both the intervention and control (if any) groups. Any disagreement was resolved by a third reviewer if necessary.
Risk of bias assessment
MNS and AB evaluated the risk of bias (ROB) of the included studies using the Cochrane ROB tool (Higgins et al., 2011). For RCTs, each ROB item was ranked as “low risk” if it was suspected that a bias would seriously alter the result, “unclear” if it was expected that a bias would raise some uncertainty about the results, or “high risk” if it was prospective that a bias would completely alter the result. A discussion was used to resolve disagreements among reviewers.
Data analysis
Data analysis for the risk of bias was executed using Microsoft Excel 2010 and Review Manager 5.3.
Results
A total of 124 articles were obtained, of which 107 were extracted from the databases mentioned and 17 were corkscrewed from Google Scholar. After the removal of 52 duplicate articles, 72 articles remained. Screening of the abstracts and titles of articles along with assessing the availability and relevancy of the full texts led to the removal of 12 articles. The remaining 60 articles were evaluated for eligibility based on the selection criteria, and 41 articles were excluded. Qualitative synthesis was performed for 19 studies. The details of these studies are depicted in the PRISMA flow diagram (Figure 1).
Out of the 19 selected articles, 6 were blinded RCTs (one triple-blind and five double-blind) and 13 were non-blinded RCTs. Eight studies were from Iran (Safarinejad et al., 2011; Khoradmehr et al., 2014; Kolahdooz et al., 2014; Rasekh et al., 2015; Ouladsahebmadarek et al., 2016; Nasimi Doost Azgomi et al., 2018; Kolangi et al., 2019; Aghajani et al., 2021), three in China (Yang et al., 2001; Peng et al., 2014; Wang et al., 2020a), four in Japan (Ishikawa et al., 1992; Furuya et al., 2004; Akashi et al., 2008; Yu et al., 2017), three in India (Rege et al., 1997a; Ahmad et al., 2010; Mahajan et al., 2012), and one in South Korea (Park et al., 2016).
Characteristics of participants
The inclusion criteria were met by 19 studies which comprised 1,398 participants. All of the participants were proven infertile according to the WHO criteria of infertility. Their sperm count was lower than 20 million per milliliter. The sample size of the chosen studies ranged from n = 20 to n = 260 (Table 2).
Risk of bias
Figures 2, 3 present ROB for all included RCTs. More than 90% of the studies were categorized as free of attrition bias, reporting bias, and other sources of bias. Performance bias and selection bias were found in only 40% of the studies.
Effects of herbs on sperm parameters
Following are the details explaining the effects of all the herbs included on sperm parameters. Table 3 summarizes the proposed mechanism of action and common side effects of all the herbs included in this review on improving semen parameters.
Y-Virilin
The effect of the herbal formulation, Y-virilin, was studied through a double-blind randomized controlled trial in India (Rege et al., 1997a). The study comprised two phases. A total of 52 patients were randomized into two equal groups: a treatment group and a placebo group. The treatment group was given one capsule of Y-virilin twice a day for 6 months. After 6 months, no significant change was observed in sperm motility and serum FSH. An increase in the sperm concentration was detected, and 25% of couples achieved pregnancy.
Hochu-ekki-to
The effect of Hochu-ekki-to, a traditional Japanese herbal medicine, was reported by three studies conducted in Japan. The first study was conducted through an experimental (single-blind) study design (Ishikawa et al., 1992). An amount of 7.5 g of the herb was administered to 67 patients daily for 3 months. A significant increase in sperm motility and sperm density was noticed. Serum density before and after treatment was 26 ± 32 × 106/ml and 38 ± 38 × 106/ml, respectively. Sperm motility was increased from 43 ± 23 × 106/ml to 54 ± 22 × 106/ml. Serum FSH was not changed.
The second study was also an experimental (single-case) study (Furuya et al., 2004). A total of 22 patients were inducted and treated with 7.5 g of herb daily for 3 months. Sperm count was increased from 28 ± 31 × 106/ml to 42 ± 32 × 106/ml. Also, sperm motility was increased from 32 ± 17% to 39 ± 19%, and a significant increase in seminal plasma soluble Fas (sFas) was observed. No noticeable change was observed in IL-6 and IL-8.
The third study was also an experimental (single-case) study (Akashi et al., 2008). A total of 20 infertile patients were treated with 7.5 g of the herb daily for 3 months. Sperm motility was increased from 33.0 ± 13.5% to 42.6 ± 15.6%, and seminal RANTES, TNF-α, and IL-6 were slightly decreased. All three studies compared the outcome values with the baseline of the same patients.
Alpinia officinarum
The effect of A. officinarum, a Chinese herbal medicine belonging to the Zingiberaceae family, was studied in Iran through a double-blind RCT (Kolangi et al., 2019). This trial comprised 76 males with idiopathic infertility, which was randomized into a treatment group and a placebo group. An amount of 100 mg of the rhizome extract of the herb was administered to the treatment group, while the placebo group received 100 mg of sucrose thrice a day for 12 weeks. No comparable change was observed in sperm motility and semen volume. Sperm count, however, was increased by 62%.
Nigella sativa
The oil of N. sativa, black cumin, belonging to the Ranunculaceae family is believed to have a positive impact on infertility in males. This effect was studied using a double-blind RCT (Kolahdooz et al., 2014). A total of 80 patients were randomized into an intervention group treated with 2.5 ml of oil twice daily, and a placebo group received 2.5 ml liquid paraffin twice daily, respectively, for 2 months. A significant increase in sperm parameters was observed in the treatment group.
Withania somnifera
An experimental (single-case) study was conducted in India to observe the effect of Withania somnifera root powder, a medicinal plant of the Indian subcontinent, with milk (Ahmad et al., 2010). A total of 150 male patients were equally distributed in the intervention group and control group. The intervention group was treated with 5 g herb daily with milk for 3 months. An increase in sperm parameters and hormones from the baseline was observed along with a decrease in lipid peroxides in the patients as compared to their baseline. Another study was conducted in Iran, a triple-blind RCT, to compare the effects of W. somnifera with pentoxifylline (Nasimi Doost Azgomi et al., 2018). A total of 100 patients were randomized into two treatment groups. Group 1 was treated with six capsules designed in two different colors (containing 5 g of the WS root) in three divided doses; in the pentoxifylline group, the subjects received six capsules in two different colors (containing 800 mg of this drug and placebo), three times a day over 90 days. Then, 12.5% increase in sperm count, 21.42% increase in motility, and 25.56% increase in morphology were observed in group 1, while a lesser increase was noticed in group 2, without affecting the sperm count. The conception rate was 18 and 12% in groups 1 and 2, respectively.
Aphrodisiac plants
Medicinal aphrodisiac plants, which include Mucuna pruriens, Chlorophytum borivilianum, and Eulophia campestris, were studied through an experimental (single-case) study in India (Mahajan et al., 2012). A total of 20 oligozoospermic patients were equally divided into the treatment group and the control group. Then, 20 mg/kg herbal composition was administered to the treatment group twice daily for 90 days. Sperm density and motility along with serum FSH, LH, and testosterone were significantly elevated after treatment in the patients as compared to their baseline.
Crocus sativus Linn
A double-blind RCT was conducted in Iran to assess the efficacy of saffron (C. sativus) (Safarinejad et al., 2011). A total of 260 patients were randomized into an intervention group and a placebo group. An amount of 30 mg of saffron was given to the treatment group twice daily, while 30 mg of starch was given to the placebo group twice a day for 26 weeks. After the treatment period, no comparable improvement was noticed in semen parameters and hormones, therefore showing saffron to be ineffective in treating male infertility.
Topalaf
Topalaf is a powdered blend of various herbs including Tribulus terrestris, Orchis mascula root, pollen of Phoenix dactylifera, the seed of Allium ampeloprasum, and the seed of Lepidium sativus, Amygdalus communis, and Ficus carica. A total of 62 patients were distributed into a treatment group and a placebo group in an experimental study (Khoradmehr et al., 2014). Topalaf was administered to the treatment group thrice a week for 3 months. A total of 12.9% increase in sperm motility and an 8.14% increase in sperm count from the baseline were noticed. However, an insignificant change in sperm morphology was observed. A total of 18.75% of couples became pregnant in the treatment group compared to 3.3% in the control.
Gushenyutai
Gushenyutai plaster is made from 23 herbs and serves as a transdermal patch. Peng et al. (2014) conducted an RCT in China to assess the extent of the effect of Gushenyutai plaster on male infertility. A total of 62 patients were randomized into a treatment and a control group. The treatment group was given Gushenyutai plaster with comprehensive therapy, and the control group was administered comprehensive therapy for 8 weeks. Significant improvement in sperm density was observed. The pregnancy rate was 38.71 and 16.13%, respectively, in the treatment and control groups.
Date palm pollen (DPP)
A total of 40 infertile males were inducted into an experimental study conducted by Rasekh et al. (2015). An amount of 120 mg/kg DPP powder capsules were given to patients every other day. After 60 days, a noticeable increase in semen concentration, morphology, and motility was observed in the patients as compared to their baseline parameters. Sperm motility was increased by 4.6%. However, the semen volume did not change significantly.
Qixiong Zhongzi
The effect of Qixiong decoction, a Chinese medicine, was studied through an RCT in China (Wang et al., 2020b). A total of 66 patients were randomly distributed into a treatment group and a control group. The treatment group was given 150 ml decoction of Qixiong Zhongzi twice a day, while the control group received 1 g of levocarnitine twice a day. No significant change was detected in the semen volume and sperm density after 12 weeks. None of the couples got pregnant. However, a significant increase in sperm motility was observed.
Korean red ginseng
Park et al. (2016) conducted a double-blinded RCT to assess the efficacy of red ginseng in male infertility. A total of 80 patients were divided into an intervention and a placebo group. The treatment group was given three 500 mg capsules of red ginseng daily for 12 weeks. At the end of the study, all sperm parameters were significantly increased, but no change was found in the plasma hormonal concentrations.
Compound herbal remedy
Ouladsahebmadarek et al. conducted an experimental study in which 40 patients were given 700 mg capsules of a compound herbal remedy once a day. The compound herbal remedy comprised Allium cepa, Cinnamomum verum, Zingiber officinale, Ocimum basilicum, Citrullus lanatus, peel of Citrus sinensis, and seeds of Daucus carota (Ouladsahebmadarek et al., 2016). A significant increase was observed in sperm parameters of the patients after 6 months, and 17.9% of couples reported pregnancy after treatment.
Tomato juice
In Japan, an RCT was conducted to evaluate the effect of tomato juice on male infertility (Yu et al., 2017). A total of 54 patients were randomized into two treatment groups and one control group. Treatment group 1 was given 30 mg lycopene (from tomato), and treatment group 2 was given an antioxidant capsule, once daily for 12 weeks. Significant improvement in sperm concentration and motility was detected in treatment group 1 by the sixth week, but no improvement was observed in group 2.
Ceratonia siliqua
A parallel randomized controlled trial was conducted to determine the efficacy of carob syrup (C. siliqua), an evergreen shrub or tree, in comparison with vitamin E as an antioxidant for the treatment of male infertility (Aghajani et al., 2021). This study comprised 60 patients randomized into two treatment groups. Group 1 received 7.5 ml of carob syrup twice a day, while group 2 received 100 mg of vitamin E twice a day for 3 months. The results showed a significant increase in semen parameters and hormonal levels of testosterone along with a significant decrease in malondialdehyde (MDA) in the carob syrup group. The vitamin E group also showed improvement in semen parameters, but it was comparatively less than the carob syrup group. The conception rate was 23% for the carob syrup group versus 13% for the vitamin E group.
Sheng Jing Zhong Zi Tang
An experimental (single-case) study tested the efficacy of the Chinese decoction, Sheng Jing Zhong Zi Tang, in patients suffering from spermatopathy (Yang et al., 2001). A total of 83 out of 87 (95.4%) spermatopathy patients were treated with the decoction, and 49 out of 87 patients were successful in getting their spouses pregnant. The results also showed that the decoction could have a dual-directional regulatory effect on the levels of follicle-stimulating hormone, luteinizing hormone, testosterone, and cortisol.
Discussion
According to the extracted data, all of the studies reported an improvement in at least one or more semen quality parameters except one study (Safarinejad et al., 2011) which reported no significant improvement upon administration of saffron. All the studies reported at least one primary outcome (concentration, morphology, or motility) except one study that reported conception and sperm density (Peng et al., 2014). The most number of studies three were conducted on Hochu-ekki-to, followed by two on Withania somnifera. Administration of Hochu-ekki-to and Withania somnifera resulted in an improvement in sperm motility and concentration and a decrease in cytokines and an improvement in the primary endpoints of semen, respectively. Therefore, these herbs show great promise and should be further studied as a treatment option for male infertility. Table 3 summarizes the proposed mechanism of action in which the herbs included in this review improve semen parameters.
The primary outcomes assessed for infertility include sperm count, motility, and morphology (Buhling et al., 2019). Other possible outcomes include conception, semen volume, hormonal levels (testosterone, follicle-stimulating hormone, luteinizing hormone, etc.), sperm density, vitality, and total motile sperm count (TMSC). There are also various endpoints existing which are indirectly linked to infertility, possibly due to any secondary cause. These include various cytokines and chemokines. For example, seminal RANTES is a chemokine and acts as a chemoattractant for WBCs in various genital infections, in which the excess can lead to infertility (Isobe et al., 2002). On the other hand, TNF-α, which can exhibit genetic polymorphism, leads to decreased sperm motility (NAZ and KAPLAN, 1994; Akashi et al., 2008; Mostafa and Taymour, 2016) whereas IL-6 and IL-8 produced by WBCs are associated with decreased sperm penetration and semen quality, respectively (Eggert-Kruse et al., 2001; Furuya et al., 2004; Akashi et al., 2008). A decrease in sFas can cause an increase in oxidative stress, thus leading to infertility (Furuya et al., 2004; Tawadrous et al., 2013). Collectively, a decreased concentration of aforementioned chemokines except for sFas (it should be increased) may lead to improvement in male infertility.
Three studies (Yu et al., 2017; Nasimi Doost Azgomi et al., 2018; Aghajani et al., 2021) compared the efficacy of herbal intervention with pharmacological (pentoxifylline) or supplement-based (vitamin C, vitamin E, and glutathione) intervention. All three of these studies reported a greater improvement in the herbal intervention group than the pharmacological or supplement-based intervention group. Nonetheless, recently, a systematic review and meta-analysis have been performed which assessed the efficacy of all the pharmacological interventions used in male infertility. According to the review, the combination of clomiphene, zinc, and testosterone, as well as CoQ10, FSH, and tamoxifen yielded the best improvements in male semen parameters (Shahid et al., 2021).
Six studies compared an intervention with a placebo (Rege et al., 1997a; Safarinejad et al., 2011; Khoradmehr et al., 2014; Kolahdooz et al., 2014; Park et al., 2016; Kolangi et al., 2019). All of these studies reported significant improvement in semen parameters, therefore reinforcing the reported efficacy of the herbal interventions used in the study.
Five studies compared an intervention with control (Ahmad et al., 2010; Mahajan et al., 2012; Peng et al., 2014; Yu et al., 2017; Wang et al., 2020b). None of the articles reported any significant improvement in the specified semen endpoints except in one study (Peng et al., 2014) which reported an increase in the sperm density and success of conception in the control group. This improvement in sperm parameters may likely be due to the comprehensive therapy that the control group received. This was the same therapy received by the treatment group with the difference being the addition of the Gushenyutai plaster which contains 23 herbs.
Some of the studies reported side effects (Safarinejad et al., 2011; Park et al., 2016; Kolangi et al., 2019; Wang et al., 2020b). These included common colds, allergic reactions, headaches, hypomania, increased appetite, and nausea. All of these adverse effects were spontaneously resolved and were assumed to not be related to the use of herbal products.
Most of the studies included in this review have shown positive trends in the semen parameters and thus present a strong case of having comparable efficacy and possibly being an alternative to pharmacological interventions in the future. However, it is really difficult to recommend herbal interventions as alternative to pharmacological interventions as it is hard to come to a conclusion about which one is most effective among those. Moreover, there were observed discrepancies with the reported clinical outcomes, and somehow, the results of trials were not comparable because of i) different treatment durations (ranging from weeks to months), ii) monotherapy (single herb vs. combinations) or combined with other therapy, iii) no standard comparative agent, iv) different extracts (no standardization on dose), v) patient number and populations with different extents and severity of infertility, and vi) inconsistent study endpoints. Caution must be exercised, however, in the use of herbs at least until the FDA and WHO approve them.
Further studies are required to compare the efficacy and safety of these herbal drugs to pharmacological drugs as well as to other possible methods (e.g., surgery). All current and future trials should be comprehensive and conform to the CONSORT guidelines (Dworkin et al., 2010). It is suggested that further studies comprise larger sample size, different doses of herbal drugs, and a longer duration of the study to maximally achieve more definitive results regarding the safety and efficacy of these drugs for male infertility.
This review may have been affected by publication bias (inherited from the trials), as is the case for all medical research practices (Easterbrook et al., 1991). Research studies on alternative medicine are more prone to publication bias than other studies (Ernst and Pittler, 1997). A narrative summary is also thought to be susceptible to subjectivity and bias to be limited when the effect size is absent (Graham, 1995). To minimize this possibility, two reviewers discussed the study outcomes, quality indicators, and the effects of shortcomings in the methodology in detail. Any disagreement was resolved by a third reviewer if necessary.
Conclusion
This systematic review has demonstrated the efficacy of herbal medicines in the treatment of male infertility. Herbs may have a role in the management of male infertility. However, more studies are warranted, and future experimental and clinical studies should be directed toward identifying the specific components and mechanisms by which identified components exert their clinical effects. The preparation of herbal products should be standardized; to ensure a degree of purification of the herbs and thus efficacy, we want to include other kinds of patients or infertility, as in the trial data, and any side effects reported should be well monitored. As far as the current systematic review is concerned, herbal medicines, especially Hochu-ekki-to and W. somnifera, are potential candidates for alternative treatment options, subject to further studies on aforementioned parameters.
Strengths and limitations
Numerous curbs are associated with this study. Due to a lack of resources, non-English studies were not reviewed as it was difficult to translate them to other languages. A combination of data from non-English literature might alter the significance of the current analysis of various male infertility interventions. Lastly, due to diversified types of male infertility along with different herbal interventions, all such interventions were classified into multiple types. Along with all the limitations, our systematic review is the first study establishing a comparison among all available herbal interventions regarding male infertility, and this comprises a very significant aspect of this work.
Clinical implications
This is perhaps the first study to compare all the available herbal interventions to improve sperm morphology, count, and male infertility health. In addition, this study has also summarized the effects of different herbal interventions which will serve as an ideal approach to optimize the therapy based on the effect size and might be useful in optimizing the cost of therapy as well. This study is of significant value for healthcare providers and policymakers in selecting the perfect blend of herbal interventions for male infertility patients, keeping in view the existing health resources. This review establishes that all herbal interventions had a significantly positive effect on male infertility. There is a need for future experimental studies on these interventions with significant effect sizes so that better pharmacotherapy can be planned to improve the outcome of therapy.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material; further inquiries can be directed to the corresponding author.
Author contributions
MS: conceptualization, methodology, software, data curation, validation, formal analysis, investigation, resources, writing, visualization, and funding acquisition. HA: investigation, resources, writing, visualization, and funding acquisition. BF: investigation, resources, writing, visualization, and funding acquisition. MY: investigation, resources, writing, visualization, and funding acquisition. MI: investigation, resources, writing, visualization, and funding acquisition. TS: investigation, resources, writing, visualization, and funding acquisition. TK: conceptualization, methodology, software, data curation, validation, formal analysis, resources, writing, visualization, supervision, and project administration. CN: conceptualization, validation, resources, supervision, and project administration. QL: conceptualization, validation, resources, supervision, and project administration. AB: methodology, resources, and supervision. MK: conceptualization, validation, resources, supervision, and project administration.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphys.2022.930676/full#supplementary-material
References
Abdi F., Roozbeh N., Mortazavian A. M. (2017). Effects of date palm pollen on fertility: Research proposal for a systematic review. BMC Res. Notes 10 (1), 363–364. doi:10.1186/s13104-017-2697-3
Agarwal A., Mulgund A., Hamada A., Chyatte M. R. (2015). A unique view on male infertility around the globe. Reprod. Biol. Endocrinol. 13 (1), 37–39. doi:10.1186/s12958-015-0032-1
Aghajani M. M. R., Mahjoub S., Mojab F., Namdari M., Gorji N. M., Dashtaki A., et al. (2021). Comparison of the effect of ceratonia siliqua l.(carob) syrup and vitamin E on sperm parameters, oxidative stress index, and sex hormones in infertile men: A randomized controlled trial. Reprod. Sci. 28 (3), 766–774. doi:10.1007/s43032-020-00314-3
Ahmad M. K., Mahdi A. A., Shukla K. K., Islam N., Rajender S., Madhukar D., et al. (2010). Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil. Steril. 94 (3), 989–996. doi:10.1016/j.fertnstert.2009.04.046
Akashi T., Watanabe A., Morii A., Mizuno I., Fuse H. (2008). Effects of the herbal medicine hochuekkito on semen parameters and seminal plasma cytokine levels (TNF-α., IL-6, RANTES) in idiopathic male infertility. J. Traditional Med. 25 (1), 6–9.
Barati E., Nikzad H., Karimian M. (2020). Oxidative stress and male infertility: Current knowledge of pathophysiology and role of antioxidant therapy in disease management. Cell. Mol. Life Sci. 77 (1), 93–113. doi:10.1007/s00018-019-03253-8
Buhling K., Schumacher A., Zu Eulenburg C., Laakmann E. (2019). Influence of oral vitamin and mineral supplementation on male infertility: A meta-analysis and systematic review. Reprod. Biomed. Online 39 (2), 269–279. doi:10.1016/j.rbmo.2019.03.099
Chachamovich J. R., Chachamovich E., Ezer H., Fleck M. P., Knauth D., Passos E. P. (2010). Investigating quality of life and health-related quality of life in infertility: A systematic review. J. Psychosom. Obstet. Gynaecol. 31 (2), 101–110. doi:10.3109/0167482X.2010.481337
Daumler D., Chan P., Lo K., Takefman J., Zelkowitz P. (2016). Men's knowledge of their own fertility: A population-based survey examining the awareness of factors that are associated with male infertility. Hum. Reprod. 31, 2781–2790. doi:10.1093/humrep/dew265
Dutta S., Biswas A., Sengupta P. (2019). Obesity, endocrine disruption and male infertility. Asian pac. J. Reprod. 8 (5), 195. doi:10.4103/2305-0500.268133
Dworkin R. H., Turk D. C., Peirce-Sandner S., Baron R., Bellamy N., Burke L. B., et al. (2010). Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 149 (2), 177–193. doi:10.1016/j.pain.2010.02.018
Easterbrook P. J., Gopalan R., Berlin J. A., Matthews D. R. (1991). Publication bias in clinical research. Lancet 337 (8746), 867–872. doi:10.1016/0140-6736(91)90201-y
Eggert-Kruse W., Boit R., Rohr G., Aufenanger J., Hund M., Strowitzki T. (2001). Relationship of seminal plasma interleukin (IL) -8 and IL-6 with semen quality. Hum. Reprod. 16 (3), 517–528. doi:10.1093/humrep/16.3.517
Esteves S. C., Hamada A., Kondray V., Pitchika A., Agarwal A. (2012). What every gynecologist should know about male infertility: An update. Arch. Gynecol. Obstet. 286 (1), 217–229. doi:10.1007/s00404-012-2274-x
Furuya Y., Akashi T., Fuse H. (2004). Effect of Bu-zhong-yi-qi-tang on seminal plasma cytokine levels in patients with idiopathic male infertility. Arch. Androl. 50 (1), 11–14. doi:10.1080/01485010490250515
Graham S. (1995). Narrative versus meta-analytic reviews of race differences in motivation: A comment on cooper and dorr. Rev. Educ. Res. 65 (4), 509–514. doi:10.3102/00346543065004509
Higgins J. P., Altman D. G., Gøtzsche P. C., Jüni P., Moher D., Oxman A. D., et al. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj 343, d5928. doi:10.1136/bmj.d5928
Ishikawa H., Manabe F., Zhongtao H., Yoshii S., Koiso K. (1992). The hormonal response to HCG stimulation in patients with male infertility before and after treatment with hochuekkito. Am. J. Chin. Med. 20 (2), 157–165. doi:10.1142/S0192415X92000163
Isobe T., Minoura H., Tanaka K., Shibahara T., Hayashi N., Toyoda N. (2002). The effect of RANTES on human sperm chemotaxis. Hum. Reprod. 17 (6), 1441–1446. doi:10.1093/humrep/17.6.1441
Khoradmehr A., Khalili M. A., Ramezani M., Vahidi S., Moein M. R., Halvaei I. (2014). Consumption of Iranian herbal medicine by infertile men can improve pregnancy outcome. Adv. Environ. Biol. 8, 874–880.
Kolahdooz M., Nasri S., Modarres S. Z., Kianbakht S., Huseini H. F. (2014). Effects of nigella sativa L. Seed oil on abnormal semen quality in infertile men: A randomized, double-blind, placebo-controlled clinical trial. Phytomedicine 21 (6), 901–905. doi:10.1016/j.phymed.2014.02.006
Kolangi F., Shafi H., Memariani Z., Kamalinejad M., Bioos S., Jorsaraei S. G. A., et al. (2019). Effect of alpinia officinarum hance rhizome extract on spermatogram factors in men with idiopathic infertility: A prospective double-blinded randomised clinical trial. Andrologia 51 (1), e13172. doi:10.1111/and.13172
Kuoti Al-Rekabi B. K., Jawad E. S., Aneed G. F., Hussein R. R. (2019). Urogenital infection and male infertility: The presence of leukocyte in semen is associated with decrease fertilization potential of human spermatozoa in infertile patients affected with leukocytospermia. Indian Jour. Foren. Med. Toxicol. 13 (4), 1262. doi:10.5958/0973-9130.2019.00475.4
Lee H. W., Kil K. J., Lee M. S. (2020). Ginseng for improving semen quality parameters: A systematic review. World J. Mens. Health 38 (3), 377–384. doi:10.5534/wjmh.190125
Mahajan G. K., Mahajan A. Y., Mahajan R. T. (2012). Efficacy of aphrodisiac plants towards improvement in semen quality and motility in infertile males. J. Complement. Integr. Med. 9, 6. doi:10.1515/1553-3840.1520
Makar R. S., Toth T. L. (2002). The evaluation of infertility. Am. J. Clin. Pathol. 117, S95–S103. doi:10.1309/W8LJ-K377-DHRA-CP0B
Marbeen M., Al-Snafi A. E., Marbut M., Allahwerdy I. (2005). The probable therapeutic effects of date palm pollen in the treatment of male infertility. Tikrit J. Pharm. Sci. 1 (1), 30–35.
Mostafa T., Taymour M. (2016). TNF-α -308 polymorphisms and male infertility risk: A meta-analysis and systematic review. J. Adv. Res. 7 (2), 185–192. doi:10.1016/j.jare.2015.07.001
Nasimi Doost Azgomi R., Nazemiyeh H., Sadeghi Bazargani H., Fazljou S. M. B., Nejatbakhsh F., Moini Jazani A., et al. (2018). Comparative evaluation of the effects of Withania somnifera with pentoxifylline on the sperm parameters in idiopathic male infertility: A triple-blind randomised clinical trial. Andrologia 50 (7), e13041. doi:10.1111/and.13041
Naz R. K., Kaplan P. (1994). Increased levels of interleukin-6 in seminal plasma of infertile men. J. Androl. 15 (3), 220–227.
Nejatbakhsh F., Shirbeigi L., Rahimi R., Abolhassani H. (2016). Review of local herbal compounds found in the Iranian traditional medicine known to optimise male fertility. Andrologia 48 (8), 850–859. doi:10.1111/and.12675
Ouladsahebmadarek E., Giasi G. S., Khaki A., Ahmadi Y., Farzadi L., Ghasemzadeh A., et al. (2016). The effect of compound herbal remedy used in male infertility on spermatogenesis and pregnancy rate. Int. J. Women's Health Reproduction Sci. 4 (4), 185–188. doi:10.15296/ijwhr.2016.41
Park H. J., Choe S., Park N. C. (2016). Effects of Korean red ginseng on semen parameters in male infertility patients: A randomized, placebo-controlled, double-blind clinical study. Chin. J. Integr. Med. 22 (7), 490–495. doi:10.1007/s11655-015-2139-9
Peng S., Zheng Y., Zheng K., Lin K., Wu J., Zheng W., et al. (2014). Effect of a comprehensive therapy plus gushenyutai plaster administered at guanyuan (CV 4) on male infertility associated with semen non-liquefaction. J. traditional Chin. Med. = Chung i tsa chih ying wen pan 34 (6), 666–672. doi:10.1016/s0254-6272(15)30080-7
Rasekh A., Jashni H. K., Rahmanian K., Jahromi A. S. (2015). Effect of palm pollen on sperm parameters of infertile man. Pak. J. Biol. Sci. 18 (4), 196–199. doi:10.3923/pjbs.2015.196.199
Rege N., Date J., Kulkarni V., Prem A., Punekar S., Dahanukar S. (1997). Effect of Y virilin on male infertility. J. Postgrad. Med. 43 (3), 64–67.
Rege N. N., Date J., Kulkarni V., Prem A. R., Punekar S. V., Dahanukar S. A. (1997). Effect of Y virilin on male infertility. J. Postgrad. Med. 43 (3), 64–67.
Rekka E. A., Kourounakis A. P., Kourounakis P. N. (1996). Investigation of the effect of chamazulene on lipid peroxidation and free radical processes. Res. Commun. Mol. Pathol. Pharmacol. 92 (3), 361–364.
Roozbeh N., Amirian A., Abdi F., Haghdoost S. (2021). A systematic review on use of medicinal plants for male infertility treatment. J. Fam. Reprod. Health 15, 74–81. doi:10.18502/jfrh.v15i2.6447
Rowe P. J., Comhaire F. H., Hargreave T. B., Mahmoud A. M. (2000). WHO manual for the standardized investigation and diagnosis of the infertile male. Cambridge, United Kingdom: Cambridge University Press.
Safarinejad M. R., Shafiei N., Safarinejad S. (2011). A prospective double-blind randomized placebo-controlled study of the effect of saffron (Crocus sativus Linn.) on semen parameters and seminal plasma antioxidant capacity in infertile men with idiopathic oligoasthenoteratozoospermia. Phytother. Res. 25 (4), 508–516. doi:10.1002/ptr.3294
Sami N., Saeed Ali T. (2012). Perceptions and experiences of women in karachi, Pakistan regarding secondary infertility: Results from a community-based qualitative study. Obstet. Gynecol. Int. 2012, 108756. doi:10.1155/2012/108756
Shahid M. N., Khan T. M., Neoh C. F., Lean Q. Y., Bukhsh A., Karuppannan M. (2021). Effectiveness of pharmacological intervention among men with infertility: A systematic review and network meta-analysis. Front. Pharmacol. 12, 638628. doi:10.3389/fphar.2021.638628
Sinclair S. (2000). Male infertility: Nutritional and environmental considerations. Altern. Med. Rev. 5 (1), 28–38.
Smith J. F., Eisenberg M. L., Millstein S. G., Nachtigall R. D., Shindel A. W., Wing H., et al. (2010). The use of complementary and alternative fertility treatment in couples seeking fertility care: Data from a prospective cohort in the United States. Fertil. Steril. 93 (7), 2169–2174. doi:10.1016/j.fertnstert.2010.02.054
Tawadrous G. A., Aziz A. A., Mostafa T. (2013). Seminal soluble Fas relationship with oxidative stress in infertile men with varicocele. Urology 82 (4), 820–823. doi:10.1016/j.urology.2013.06.018
Wang F., Gao Q-h., Geng Q., Han Q., Zhao J-y., Yu G-j., et al. (2020). Effectiveness and safety evaluation of Qixiong zhongzi decoction () in idiopathic asthenozoospermia treatment: A randomized controlled trial. Chin. J. Integr. Med. 26 (2), 146–151. doi:10.1007/s11655-020-3211-7
Wang M., Wang Q., Du Y., Jiang H., Zhang X. (2020). Vitamins combined with traditional Chinese medicine for male infertility: A systematic review and meta‐analysis. Andrology 8 (5), 1038–1050. doi:10.1111/andr.12787
Wright C., Milne S., Leeson H. (2014). Sperm DNA damage caused by oxidative stress: Modifiable clinical, lifestyle and nutritional factors in male infertility. Reprod. Biomed. Online 28 (6), 684–703. doi:10.1016/j.rbmo.2014.02.004
Yang B., Zhang C., Du L., Xue W., Zou P. (2001). The therapeutic effects of Sheng Jing Zhong Zi Tang in treating male infertility. J. traditional Chin. Med. = Chung i tsa chih ying wen pan 21 (2), 96–99.
Keywords: male infertility, herbal interventions, systematic review, semen parameters, Hochu-ekki-to, W. somnifera, complementary and alternative medicine
Citation: Shahid MN, Afzal HS, Farooq B, Yousaf MR, Ijaz MR, Shafqat TA, Khan TM, Neoh CF, Lean QY, Bukhsh A and Karuppannan M (2022) A systematic review on the effectiveness of herbal interventions for the treatment of male infertility. Front. Physiol. 13:930676. doi: 10.3389/fphys.2022.930676
Received: 21 June 2022; Accepted: 26 September 2022;
Published: 04 November 2022.
Edited by:
Ricardo Pimenta Bertolla, Federal University of São Paulo, BrazilReviewed by:
Mariana Camargo, Federal University of São Paulo, BrazilLaura Maria Mongioì, University of Catania, Italy
Copyright © 2022 Shahid, Afzal, Farooq, Yousaf, Ijaz, Shafqat, Khan, Neoh, Lean, Bukhsh and Karuppannan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Muhammad Nabeel Shahid, bmFiZWVsc2hhaGlka0Bob3RtYWlsLmNvbQ== Mahmathi Karuppannan, bWFobWF0aGlAdWl0bS5lZHUubXk=